ICD-10 Code C91.A2 | Mature B-cell leukemia Burkitt-type, in relapse Symptoms, Diagnosis, Billing

Mature B-cell leukemia Burkitt-type, in relapse is a hematological malignancy characterized by the proliferation of malignant B-cells. This condition is clinically significant as it indicates a return of the disease after a period of remission, necessitating prompt and accurate diagnosis for effective treatment. The ICD-10 Code C91.A2 facilitates precise documentation, billing, and public health reporting, ensuring that healthcare providers can track and manage this aggressive form of leukemia effectively.

What is ICD-10 Code C91.A2 for Mature B-cell leukemia Burkitt-type, in relapse?

ICD-10 Code C91.A2 represents Mature B-cell leukemia Burkitt-type, in relapse, a condition where previously treated Burkitt lymphoma returns. This code is essential for accurately documenting the patient's clinical status, guiding treatment decisions, and ensuring appropriate billing. It should be used when a patient presents with signs of relapse after initial treatment, indicating the need for further intervention.

ICD-10 Code C91.A2 – Clinical Definition and Explanation of Mature B-cell leukemia Burkitt-type, in relapse

Mature B-cell leukemia Burkitt-type, in relapse occurs when malignant B-cells re-emerge after a period of remission, often presenting with aggressive symptoms. This condition requires immediate medical attention due to its rapid progression and potential complications. Understanding its clinical features is crucial for timely diagnosis and management.

Key Clinical Features:

• Rapidly enlarging lymph nodes, often in the abdomen or neck.
• Fever, night sweats, and unexplained weight loss.
• Bone marrow involvement leading to cytopenias.
• Elevated lactate dehydrogenase (LDH) levels indicating high tumor burden.

ICD-10 Code C91.A2 for Mature B-cell leukemia Burkitt-type, in relapse – SOAP Notes & Clinical Use

In SOAP notes, ICD-10 Code C91.A2 is utilized to document the patient's symptoms, assessment findings, and treatment plans. This code is relevant in both acute and chronic care settings, ensuring that the patient's relapse is accurately recorded and managed within clinical workflows.

What Does ICD-10 Code C91.A2 for Mature B-cell leukemia Burkitt-type, in relapse Mean in SOAP Notes?

ICD-10 Code C91.A2 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of relapse. This code is vital for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code C91.A2 – Mature B-cell leukemia Burkitt-type, in relapse

Mature B-cell leukemia Burkitt-type, in relapse requires urgent intervention, often necessitating hospitalization for intensive treatment.

Antibiotic Therapy:

• Not applicable as this is not an infectious condition.

Supportive Care:

• Chemotherapy regimens such as cyclophosphamide, doxorubicin, vincristine, and prednisone.
• Supportive transfusions for anemia and thrombocytopenia.
• Management of tumor lysis syndrome with hydration and allopurinol.

Infection Control:

• Implement standard precautions to prevent infection due to immunosuppression.
• Monitor for signs of infection closely during treatment.

How to Document Symptoms of Mature B-cell leukemia Burkitt-type, in relapse (ICD-10 C91.A2) in SOAP Notes

Subjective:

• Patient reports increased fatigue and weakness over the past month.
• Notable weight loss of 10 pounds in the last two weeks.
• Experiencing night sweats and intermittent fevers.
• Reports abdominal discomfort and noticeable swelling in the neck.

Objective:

• Physical examination reveals enlarged cervical and abdominal lymph nodes.
• Laboratory tests show elevated LDH and low hemoglobin levels.
• Bone marrow biopsy indicates >30% blast cells.
• Vital signs: temperature 101°F, heart rate 110 bpm.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Mature B-cell leukemia Burkitt-type, in relapse (ICD-10 Code C91.A2)

Assessment:

• Diagnosis: Mature B-cell leukemia Burkitt-type, in relapse, severe.
• ICD-10 Code: C91.A2.
• Triggers: Previous treatment failure and possible infection.
• Complications: Risk of tumor lysis syndrome and severe cytopenias.

Plan:

• Initiate chemotherapy regimen as per protocol.
• Provide supportive care including blood transfusions as needed.
• Educate patient on signs of infection and when to seek immediate care.
• Schedule follow-up appointments for monitoring treatment response.

Treatment & Plan Section for ICD-10 Code C91.A2 – Mature B-cell leukemia Burkitt-type, in relapse

• First-line treatment includes intensive chemotherapy regimens.
• Non-pharmacologic strategies involve nutritional support and psychosocial counseling.
• Monitoring includes regular CBCs and LDH levels to assess treatment response.
• Follow-up practices should include imaging studies to evaluate disease status.

Using ICD-10 Code C91.A2 for Mature B-cell leukemia Burkitt-type, in relapse in Billing & SOAP Note Compliance

• Select accurate subcodes based on clinical severity or complications.
• Document symptoms clearly under Subjective (S) and Objective (O) in SOAP notes.
• Ensure treatment plans align with clinical guidelines to support justified billing.
• Only list CPT codes that are commonly billed with ICD-10 Code C91.A2 based on standard medical coding practices.

Related ICD-10 Codes Often Used with Mature B-cell leukemia Burkitt-type, in relapse

• C91.A1 – Mature B-cell leukemia, not in relapse

ICD-10 Code C91.A2 in Medical Billing and Insurance for Mature B-cell leukemia Burkitt-type, in relapse

ICD-10 Code C91.A2 is crucial for accurate billing in hospital, ER, or infectious disease care settings.

Billing Notes:

• Ensure documentation includes detailed clinical findings and treatment plans.
• Use this code in settings where the patient is receiving intensive treatment for relapse.
• Highlight key chart elements such as lab results and treatment responses to support claims.
• Maintain compliance with coding guidelines to avoid denials.

Common CPT Pairings: